Nelson Peltz, through his hedge fund Trian Fund Management, engages in high-profile proxy battles with undervalued companies, even if he doesn't secure board seats.
Despite not always achieving his goals, many companies influenced by Peltz end up adopting several of his proposals, reflecting his impactful strategy.
With Trian managing $7.1 billion in assets and a concentrated portfolio, Peltz consistently seeks to enhance the performance of the companies he invests in.
After the recent addition of three new stocks, Peltz's involvement with Rentokil Initial has shifted from passive to activist, particularly following a profit warning from the company.
Collection
[
|
...
]